Biopolymer Carriers
Biopolymer Carriers - Related Videos
08:13
Preparation of Biopolymer Aerogels Using Green Solvents
0 Views •
Cited by 44 •
2016
A new way for the production of biopolymer-based aerogels by carbon dioxide (CO2) induced gelation is shown. The technique utilizes pressurized carbon dioxide (5 MPa) for the production of biopolymer hydrogels and supercritical CO2 (12 MPa) to convert gels into aerogels. The only solvents needed besides CO2 are water and ethanol.
07:06
Methods for the Self-integration of Megamolecular Biopolymers on the Drying Air-LC Interface
0 Views •
Cited by 4 •
2017
A method for the drying-induced self-integration of megamolecular biopolymers on the air-liquid crystalline interface is provided here. This methodology will be useful not only for understanding the macroscopic potentials of biopolymers, but also as an evaluation method for soft materials in biomedical and environmental fields.
01:24
Electron Carriers
0 Views •
2019
Electron carriers can be thought of as electron shuttles. These compounds can easily accept electrons (i.e., be reduced) or lose them (i.e., be oxidized). They play an essential role in energy production because cellular respiration is contingent on the flow of electrons. Over the many stages of cellular respiration, glucose breaks down into carbon dioxide and water. Electron carriers pick up electrons lost by glucose in these reactions, temporarily storing and releasing them into the electron...
01:18
Thermally Responsive Biopolymer-Based Inhibition of Tumor Progression in a Rat Model
0 Views •
2025
Begin with an anesthetized rat bearing a brain tumor composed of proliferating tumor cells.Expose the rat’s skull and create a hole to reveal the brain region with the tumor.Take a thermally responsive biopolymer fused with a cell-penetrating peptide and an inhibitor of c-myc, an oncogenic protein.Inject the biopolymer into the femoral vein of the hind limb for delivery to the brain.Apply infrared light through the skull hole to heat the tumor site, which induces biopolymer aggregation along...
07:59
Molecular Entanglement and Electrospinnability of Biopolymers
0 Views •
Cited by 13 •
2014
Electrospinning is a fascinating technique used to fabricate micro- to nano-scale fibers from a wide variety of materials. Molecular entanglement of the constituent polymers in the spinning dope is essential for successful electrospinning. We present a protocol for utilizing rheology to evaluate the electrospinnability of two biopolymers, starch and pullulan.
FAQs
Payload availability is governed by several linked processes within the polymer system. Drug molecules may move outward by diffusion, while water-driven swelling can alter the pathway through the matrix. Gradual biodegradation can also open or break down the carrier over time. Together, these mechanisms help determine how steadily a therapy is released under physiological conditions.
Encapsulation places the therapeutic molecule inside the carrier, whereas binding associates it with the polymer matrix. Both arrangements can influence stability and release, but the way the payload interacts with the polymer affects how it becomes available. This distinction helps guide carrier architecture when researchers seek controlled handling of a drug under physiological conditions.
Composition and architecture are key variables because they shape how the payload is held, protected, and released. These features can support the handling of compounds that are poorly soluble or unstable, while also influencing where treatment is distributed. Adjusting the carrier system therefore connects material design with therapeutic availability and possible concentration at selected tissues.
Researchers consider how the polymer will hold the therapeutic molecule and which release process should govern its availability. Diffusion, swelling, and gradual biodegradation provide different ways to regulate release under physiological conditions. The design goal is to align these carrier behaviors with the need for improved stability, distribution, or gradual delivery of the selected treatment.
The source identifies vaccines and nucleic-acid delivery as applications enabled by the composition and architecture of biopolymer-based systems. In these settings, the carrier can provide a way to transport the relevant therapeutic or biological payload while influencing its stability, distribution, and release. Their value therefore extends beyond conventional small-molecule drug delivery.
Their adaptable composition and architecture support applications in regenerative medicine and personalized therapies, where delivery requirements may differ between treatments or tissues. By helping control payload stability, distribution, and release, these systems can be matched to a particular therapeutic context. This flexibility also complements efforts to concentrate treatment at selected tissues rather than relying only on general distribution.